Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations [1]

Breast Journal

Volumn 12, Issue 3, 2006, Pages 280-281

  Silva, Edibaldo ^a   Lynch, Henry ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ALGORITHM; BREAST CANCER; CANCER ADJUVANT THERAPY; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; HUMAN; LETTER; ONCOGENE;

BREAST NEOPLASMS; DECISION TREES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; NEOPLASM PROTEINS;

EID: 33646232751     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00260.x     Document Type: Letter

References (2)

1. Stolier AJ Furnham GM Mauterer L Bolton JS Superneau DW Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation Breast J 2004 10 475 80
2. Chung MA Cady B Surgical treatment planning in newly diagnosed breast cancer patients at high risk for BRCA-1 or BRCA-2 mutation Breast J 2004 10 473 74